WHERE TO WATCH
Russell 2000 Sees Record Close as Major Averages Fall on Fading Vaccine Optimism
November 17, 2020
Shah Gilani, chief investment strategist at Money Map Press, breaks down the markets after big tech's day on Capitol Hill and upcoming vaccine news.
Cheddar Morning News Briefing of November 27th
Nov 16, 2020
Dow, S&P, Russell 2000 Close at Record Levels After Promising Moderna Vaccine Data
The Dow, S&P, and Russell 2000 all closed at record highs Monday after Moderna announced promising data on its coronavirus vaccine candidate. Michael Robinson, chief technology strategist at Money Map Press, breaks down the Monday markets.
Nov 24, 2020
Dow Closes Above 30,000 for First Time Ever as S&P 500, Russell 2000 Also Close at All-Time Highs
Tuesday was a banner day on Wall Street, as the Dow closed above 30,000 for the first time ever. The S&P 500 and Russell 2000 also joined in on the fun, closing at all-time highs as well. Dan Geltrude, Managing Partner at Geltrude & Company says it's 'absolutely incredible' that the market was able to rebound from the lows of the coronavirus pandemic and reach record levels.
Nov 23, 2020
Stocks Jump on Another Positive Monday for Vaccines
Astrazeneca's vaccine candidate with Oxford University shows an average efficacy of 70 percent, while Moderna reported an estimated 94.5 percent. Pfizer and BioNTech now say theirs is 95 percent effective. Andrew Smith, chief investment strategist at Delos Capital Advisors, joined Cheddar to discuss.